Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose Oral Montelukast for Pediatric Acute Asthma
NCT03277170Phase 2Withdrawn
- Sponsor
- Vanderbilt University Medical Center
- Start
- Sep 2025
- Primary completion
- Aug 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of montelukast in asthma, sponsored by Vanderbilt University Medical Center. Planned start Sep 2025; status: withdrawn.
02
Drugs
montelukast
03
Conditions
asthma
Beyond the preview
Go deeper on NCT03277170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03277170.